Benefits promoted by the use of a highly bioavailable fermentation-produced nutraceutical, rich in β-glucans and amino acids, for cancer patients treated with chemotherapy and radiotherapy
DOI:
https://doi.org/10.33448/rsd-v11i15.36983Keywords:
Supplementation; β-glucans; Amino acids; Oncological patients; Chemotherapy; Radiotherapy; Bionutri AR1®.Abstract
Cancer patients are generally submitted to chemotherapy and radiotherapy, which tend to cause problems related to intense inflammatory processes, malnutrition, nausea and emesis. Therefore, performing supplementation in these patients is important and necessary, as it favors cancer patients from a nutritional point of view. Studies show that supplementation with β-glucans promotes benefits to cancer patients undergoing chemotherapy and radiotherapy. Amino acids and β-glucans obtained from fermentation processes proved to be important in the care of cancer patients, because they improve the nutritional parameters and general condition of the patient. Thus, this work aims to discuss the benefits obtained by cancer patients undergoing chemotherapy and radiotherapy who received supplementation with a fermented nutraceutical rich in β-glucans and amino acids. A literature review was carried out through an active search for scientific articles through the use of the following descriptors in Portuguese: β-glucans, amino acids, cancer patients, chemotherapy and radiotherapy. In addition, we also discuss the benefits caused by the use of the product called Bionutri AR1®, a nutraceutical that contributes to the recovery of nutritional status, indicated for patients with severe malnutrition induced by cancer and the therapeutic approaches chemotherapy and radiotherapy. We conclude that the use of products capable of promoting supplementation of β-glucans and amino acids is extremely beneficial to cancer patients, especially those undergoing chemotherapy and radiotherapy and, therefore, there is an indication of supplementation for these patients with the fermented product Bionutri AR1®.
References
Argilés J. M. (2005). Cancer-associated malnutrition. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 9 Suppl 2, S39–S50. https://doi.org/10.1016/j.ejon.2005.09.006.
Behall, K. M., Scholfield, D. J., Hallfrisch, J. G., & Liljeberg-Elmståhl, H. G. (2006). Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care, 29(5), 976–981. https://doi.org/10.2337/diacare.295976
Boligon, C. S., & Huth, A. (2011). O Impacto do Uso de Glutamina em Pacientes com tumores de cabeça e pescoço em tratamento radioterápico e quimioterápico. Revista Brasileira de Cancerologia; 57(1): 31-38.
Carling D. (2017). AMPK signalling in health and disease. Current Opinion in Cell Biology, 45, 31–37. https://doi.org/10.1016/j.ceb.2017.01.005.
Carvalho, A.C.L., Martins, P.C., Araujo, R.B., Cerdeira, C.D., Silva, R.B.V., & Baros, G.B.S. (2018). Parâmetros Nutricionais em Pacientes Oncológicos atendidos em um Centro de Referência no Sul de Minas Gerais, Brasil. Revista Brasileira de Cancerologia; 64(2): 159-166.
Cencioni, C., Trestini, I., Piro, G., Bria, E., Tortora, G., Carbone, C., & Spallotta, F. (2022). Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients, 14(8), 1542. https://doi.org/10.3390/nu14081542.
Demir, G., Klein, H. O., Mandel-Molinas, N., & Tuzuner, N. (2007). Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. International Immunopharmacology, 7(1), 113–116. https://doi.org/10.1016/j.intimp.2006.08.011.
Di Luzio, N. R., Williams, D. L., McNamee, R. B., Edwards, B. F., & Kitahama, A. (1979). Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. International Journal of Cancer, 24(6), 773–779. https://doi.org/10.1002/ijc.2910240613.
Dillon, E. L., Volpi, E., Wolfe, R. R., Sinha, S., Sanford, A. P., Arrastia, C. D., Urban, R. J., Casperson, S. L., Paddon-Jones, D., & Sheffield-Moore, M. (2007). Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clinical Nutrition (Edinburgh, Scotland), 26(6), 736–743. https://doi.org/10.1016/j.clnu.2007.07.004.
Eagles, J. R., & Jimeno, A. (2016). Cobimetinib: inhibiting MEK1/2 in BRAF V600-mutant melanoma. Drugs of Today (Barcelona, Spain: 1998), 52(11), 593–605. https://doi.org/10.1358/dot.2016.52.11.2542234.
Errante, P. R., Menezes-Rodrigues, F. S., Leite, A. A., Caricati-Neto, A., & Bergantin, L. B. (2016). New antitumoral pharmacological strategies involving Ca2+ camp signaling pathways. Journal of Cancer Epidemiology and Prevention, 2(1).
Errante, P. R., Neto, A. C., & Bergantin, L. B. (2017). Insights for the inhibition of cancer progression: Revisinting Ca2+ and cAMP signalling pathways. Advances in Cancer Prevention, 2: e103. https://doi.org/10.4172/2472-0429.1000e103.
Errante, P. R., Rodrigues, F. S. M., Leite, A. A., Caricati-Neto, A., & Bergantin, L. B. (2017) The Second Messengers Ca2+ and camp as Potential Therapeutic Targets for the Control of Cancer Progression. Advances in Cancer Prevention, 2: e105. doi:10.4172/2472-0429.1000e105.
Ellsworth, D. L., Blackburn, H. L., Shriver, C. D., Rabizadeh, S., Soon-Shiong, P., & Ellsworth, R. E. (2017). Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis. Clinical and Translational Medicine, 6(1), 15. https://doi.org/10.1186/s40169-017-0145-6.
Fuller, R., Moore, M. V., Lewith, G., Stuart, B. L., Ormiston, R. V., Fisk, H. L., Noakes, P. S., & Calder, P. C. (2017). Yeast-derived β-1,3/1,6 glucan, upper respiratory tract infection and innate immunity in older adults. Nutrition (Burbank, Los Angeles County, Calif.), 39-40, 30–35. https://doi.org/10.1016/j.nut.2017.03.003.
Gonzalez, M. C., Borges, L. R., Silveira, D. H., Assunção, M. C. F., & Orlandi, S. P. (2010). Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Revista Brasileira de Nutrição Clínica, Porto Alegre, 25(2), 102-108.
Hnisz, D., Weintraub, A. S., Day, D. S., Valton, A. L., Bak, R. O., Li, C. H., Goldmann, J., Lajoie, B. R., Fan, Z. P., Sigova, A. A., Reddy, J., Borges-Rivera, D., Lee, T. I., Jaenisch, R., Porteus, M. H., Dekker, J., & Young, R. A. (2016). Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science (New York, N.Y.), 351(6280), 1454–1458. https://doi.org/10.1126/science.aad9024.
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., Salm, M., Horswell, S., Escudero, M., Matthews, N., Rowan, A., Chambers, T., Moore, D. A., Turajlic, S., Xu, H., & Lee, S. M. (2017). Tracking the Evolution of Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 376(22), 2109–2121. https://doi.org/10.1056/NEJMoa1616288.
Kachalaki, S., Ebrahimi, M., Mohamed Khosroshahi, L., Mohammadinejad, S., & Baradaran, B. (2016). Cancer chemoresistance; biochemical and molecular aspects: a brief overview. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 89, 20–30. https://doi.org/10.1016/j.ejps.2016.03.025.
Kim, K. S., & Yun, H. S. (2006). Production of soluble β-glucan from the cell wall of Saccharomyces cerevisiae. Enzyme and Microbial Technology, New York, 39(3), 496-500.
Kim, S. Y., Song, H. J., Lee, Y. Y., Cho, K. H., & Roh, Y. K. (2006). Biomedical issues of dietary fiber beta-glucan. Journal of Korean Medical Science, 21(5), 781–789. https://doi.org/10.3346/jkms.2006.21.5.781.
Ko, Y. T., & Lin, Y. L. (2004). 1,3-beta-glucan quantification by a fluorescence microassay and analysis of its distribution in foods. Journal of agricultural and food chemistry, 52(11), 3313–3318. https://doi.org/10.1021/jf0354085.
Kogan, G., Sandula, J., Korolenko, T. A., Falameeva, O. V., Poteryaeva, O. N., Zhanaeva, S. Y., Levina, O. A., Filatova, T. G., & Kaledin, V. I. (2002). Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator--yeast carboxymethyl glucan. International Immunopharmacology, 2(6), 775–781. https://doi.org/10.1016/s1567-5769(02)00015-2.
Kuroda, Y., & Hara, Y. (1999). Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutation Research, 436(1), 69–97. https://doi.org/10.1016/s1383-5742(98)00019-2.
Lin, H., She, Y. H., Cassileth, B. R., Sirotnak, F., & Cunningham Rundles, S. (2004). Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. International Immunopharmacology, 4(1), 91–99. https://doi.org/10.1016/j.intimp.2003.10.012.
Matuoka-Chiocchetti, G., Viana, L. R., Lopes‐Aguiar, L., da Silva Miyaguti, N. A., & Gomes‐Marcondes, M. C. C. (2022). Nutraceuticals Approach as a Treatment for Cancer Cachexia. Handbook of Nutraceuticals and Natural Products: Biological, Medicinal, and Nutritional Properties and Applications, 1, 273-300.
Magnani, M., & Castro-Gomez, R.J.H. (2008). β-glucana de Saccharomyces cerevisiae:constituição, bioatividade e obtenção. Semina: Ciências Agrárias, Londrina, 29(3), 631-650.
Maiuolo, J., Gliozzi, M., Carresi, C., Musolino, V., Oppedisano, F., Scarano, F., Nucera, S., Scicchitano, M., Bosco, F., Macri, R., Ruga, S., Cardamone, A., Coppoletta, A., Mollace, A., Cognetti, F., & Mollace, V. (2021). Nutraceuticals and Cancer: Potential for Natural Polyphenols. Nutrients, 13(11), 3834. https://doi.org/10.3390/nu13113834.
Miadokova, E., Svidova, S., Vlckova, V., Duhova, V., Prazmariova, E., Tothova, K., Nadova, S., Kogan, G., & Rauko, P. (2005). The role of natural biopolymers in genotoxicity of mutagens/carcinogens elimination. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, 149, 493-496.
Miranda, M. P., & Souza, D. S. (2015). Glutamina na Prevenção e Tratamento da Mucosite em Pacientes Adultos Oncológicos: uma Revisão Sistemática da Literatura. Revista Brasileira de Cancerologia, 61(3), 277-285.
Miola, T. M. (2016). Avaliação do estado nutricional de pacientes atendidos em ambulatório de quimioterapia. Nutrição Brasil, 15(1): 30-35.
Moon, S. H., Heo, J. C., Fine, R. L., Kim, H. M., Kim, S. U., Yoon, B. D., & Lee, S. H. (2005). BRD-glucan exhibits potent immunochemotherapeutic activity in vitro and in vivo. International Journal of Oncology, 26(2), 395–404.
Morigi, C. (2017). Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. Ecancermedicalscience, 11, 732. https://doi.org/10.3332/ecancer.2017.732.
Muscaritoli, M., Lucia, S., Farcomeni, A., Lorusso, V., Saracino, V., Barone, C., Plastino, F., Gori, S., Magarotto, R., Carteni, G., Chiurazzi, B., Pavese, I., Marchetti, L., Zagonel, V., Bergo, E., Tonini, G., Imperatori, M., Iacono, C., Maiorana, L., Pinto, C., … PreMiO Study Group (2017). Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget, 8(45), 79884–79896. https://doi.org/10.18632/oncotarget.20168
Oliveira, T. (2007). A importância do acompanhamento nutricional para pacientes com câncer. Prática Hospitalar, 51(3): 150-4.
Pohorska, J., Richter, J., Kral, V., Rajonohova, D. L., Stiborova, I., & Vetvicka, V. (2016). Reconstruction of NK cells during complex cancer treatment. Journal of Tumor, 4, 398–402.
Prado, C. D., & Campos, J. A. D. B. (2015). Malnutrition in patients with gastrointestinal cancer: effectiveness of different diagnostic methods. Nutricion hospitalaria, 32(1), 182–188. https://doi.org/10.3305/nh.2015.32.1.8657.
Ravasco P. (2015). Nutritional approaches in cancer: relevance of individualized counseling and supplementation. Nutrition (Burbank, Los Angeles County, Calif.), 31(4), 603–604. https://doi.org/10.1016/j.nut.2014.12.001.
Sagar, B., Lin, Y. S., & Castel, L. D. (2017). Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective. Journal of Medical Economics, 20(10), 1018–1023. https://doi.org/10.1080/13696998.2017.1339353.
Tartari, R. F., Busnello, F. M., Nunes, C. H. A. (2010). Perfil Nutricional de Pacientes em Tratamento Quimioterápico em um Ambulatório Especializado em Quimioterapia. Revista Brasileira de Cancerologia, 56(1): 43-50.
Uchida C. (2016). Roles of pRB in the Regulation of Nucleosome and Chromatin Structures. BioMed Research International, 2016, 5959721. https://doi.org/10.1155/2016/5959721.
Van Cutsem, E., & Arends, J. (2005). The causes and consequences of cancer-associated malnutrition. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 9 Suppl 2, S51–S63. https://doi.org/10.1016/j.ejon.2005.09.007.
Vetvicka, V., Richter, J., Kral, V., Dobiasova, L. R., Stiborova I., & Pohorska J. (2015). Regulation of hematopoiesis in câncer patients: placebo-driven, double-blind clinical trails of β-glucan. Journal of Tumor. 3: 305–308.
Vetvicka, V., Vannucci, L., Sima, P., & Richter, J. (2019). Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules (Basel, Switzerland), 24(7), 1251. https://doi.org/10.3390/molecules24071251.
Vosgerau, D. S. A. R. & Romanowski, J. P. (2014) Estudos de revisão: implicações conceituais e metodológicas. Revista de Diálogo Educacional, (14)41, 165-189.
Waitzberg, D. L. Novas oportunidades para o uso de aminoácidos parenterais – glutamina. (2008). Revista Brasileira de Medicina, 65(6): 66.
Xue, H., Le Roy, S., Sawyer, M., Field, C., Dieleman, L., & Baracos, V. (2009). Single and combined supplementation of glutamine and n-3 polyunsaturated fatty acids on host tolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11)/5-fluorouracil chemotherapy in rats bearing Ward colon tumour. British Journal of Nutrition, 102(3), 434-442. doi:10.1017/S0007114508199482.
Yajid, A. I., Zakariah, M. A., Mat Zin, A. A., & Othman, N. H. (2017). Potential Role of E4 Protein in Human Papillomavirus Screening: a Review. Asian Pacific Journal of Cancer Prevention : APJCP, 18(2), 315–319. https://doi.org/10.22034/APJCP.2017.18.2.315.
Yun, C. H., Estrada, A., Van Kessel, A., Park, B. C., & Laarveld, B. (2003). Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunology and Medical Microbiology, 35(1), 67–75. https://doi.org/10.1016/S0928-8244(02)00460-1
Zegarska, B., Pietkun, K., Zegarski, W., Bolibok, P., Wiśniewski, M., Roszek, K., Czarnecka, J., & Nowacki, M. (2017). Air pollution, UV irradiation and skin carcinogenesis: what we know, where we stand and what is likely to happen in the future? Postepy Dermatologii i Alergologii, 34(1), 6–14. https://doi.org/10.5114/ada.2017.65616.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Edilaine Maria Stella da Cruz; Hezio Jadir Fernandes Junior; Fernando Sabia Tallo; Marcelo Pires-Oliveira; Antonio Lucas Duarte Nicolau; Rafael Guzella de Carvalho; Flávia de Sousa Gehrke; Afonso Caricati-Neto; Murched Omar Taha; Francisco Sandro Menezes Rodrigues
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
